Express Scripts is warning that the price of Gilead Sciences’ Sovaldi is unsustainable and will break the country. If everyone with hepatitis C was treated with Sovaldi, the cost would exceed $300 billion – companies simply will NOT be able to handle that! So, what is action is Express Scripts calling for? Read here to find out. (Source: Matthew Dennis, FirstWord Pharma, 4/8/14).
You are here: / / Gilead’s New Hepatitis Drug – The Cost Could Be Far Greater Than Its $84,000 Price Tag!